Cutting Edge Spine Gains FDA Clearance of EVOLha-DLIF
Cutting Edge Spine received FDA 510(k) clearance of the EVOL®ha-DLIF direct lateral interbody fusion system. Jan 09, 2020
Silver Bullet Therapeutics Gains CE Mark for OrthoFuzIon Bone Screw
Silver Bullet Therapeutics received CE Mark approval for the OrthoFuzIon™ Bone Screw for reduction and internal fixation procedures anywhere in the body. Jan 09, 2020
Royal Biologics Launches MAGNUS DMSO-Free Viable Cellular Bone Allograft
Royal Biologics launched MAGNUS, a viable cellular bone allograft that uses a DMSO-free cryoprotectant. Jan 09, 2020
Episurf Medical Receives CE Mark for Episealer Talus and Talus Osteotomy Guide
Episurf Medical received approval under the CE Mark for the Episealer® Talus and Talus Osteotomy Guide. Jan 09, 2020
Bone Biologics Study Shows Bone Formation in Spine Model
Preclinical animal study results indicate that Bone Biologics' rhNELL-1 growth factor effectively promoted bone formation in a spine model. Jan 07, 2020
Medtronic Releases Field Safety Notice for Mazor X
Medtronic issued an urgent field safety notice regarding the potential for the Mazor X Surgical System with Positioner Type II to detach from the O.R. table unexpectedly. Jan 07, 2020
Carmell Therapeutics Gains IND Application Clearance for Bone Healing Accelerant
Carmell Therapeutics announced FDA clearance of an Investigational New Drug application for the company’s Bone Healing Accelerant and enrollment in a pivotal study for long bone fractures. Jan 07, 2020
Medicrea Awarded 7 New U.S. Patents
Medicrea was issued seven additional U.S. patents related to its proprietary UNiD™ Adaptive Spine Intelligence technology platform. Jan 07, 2020
Naviswiss Gains Japan Regulatory Approval for Hip Navigation
Naviswiss is entering the Japanese market with its miniaturized surgical navigation for hip replacement. Jan 07, 2020
Johnson & Johnson to Acquire Remaining Stake in Verb Surgical
Johnson & Johnson, parent to DePuy Synthes Companies, entered into an agreement to acquire the remaining ownership stake in Verb Surgical. The transaction is expected to close in 1H20. Jan 07, 2020
